A$0.035 0.0 6.1%
Last Trade - 17/01/20
| Market Cap | £27.5m |
| Enterprise Value | £25.3m |
| Revenue | £79.3k |
| Position in Universe | 878th / 1833 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | TTM | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|---|
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Anteotech Ltd, formerly Anteo Diagnostics Ltd, is an Australia-based nano-technology company. It is a surface chemistry company, which is engaged in the development and commercialization of specialized surfaces used in life sciences, and the research and development of surfaces for specific binding of proteins (abiotics). The Company owns a growing suite of technologies in nanometre-thin primers, binders and coatings. Anteo’s nanoglue technology, called Mix&Go is developed for healthcare markets. Anteo Technologies Pty Ltd is a fully-owned subsiduary of the Company.
| Last Annual | June 30th, 2019 |
| Last Interim | June 30th, 2019 |
| Incorporated | June 26, 1995 |
| Public Since | April 11, 2000 |
| No. of Shareholders: | n/a |
| No. of Employees: | 24 |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 1,491,707,400 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Brisbane Technology Park,SE 4 26 Brandl St, EIGHT MILE PLAINS, 4113, Australia |
| Web | https://www.anteotech.com/ |
| Phone | +61 7 32190085 |
| Contact | () |
| Auditors | BDO Audit Pty Ltd |
